Page last updated: 2024-10-30

leflunomide and Bile Duct Obstruction, Extrahepatic

leflunomide has been researched along with Bile Duct Obstruction, Extrahepatic in 1 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Research Excerpts

ExcerptRelevanceReference
"Treatment with leflunomide markedly reduced serum transaminase activities as compared to BDL rats."1.33Hepatic damage in biliary-obstructed rats is ameliorated by leflunomide treatment. ( Fadillioglu, E; Iraz, M; Karadag, N; Karaman, A; Kirimlioglu, H; Tas, E, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Karaman, A1
Iraz, M1
Kirimlioglu, H1
Karadag, N1
Tas, E1
Fadillioglu, E1

Other Studies

1 other study available for leflunomide and Bile Duct Obstruction, Extrahepatic

ArticleYear
Hepatic damage in biliary-obstructed rats is ameliorated by leflunomide treatment.
    Pediatric surgery international, 2006, Volume: 22, Issue:9

    Topics: Analysis of Variance; Animals; Cholestasis, Extrahepatic; Female; Immunosuppressive Agents; Isoxazol

2006